Magnesium Fluoride Cell Imitation for Imaging Calibration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current marker-free imaging technologies lack permanent test standards for validation and calibration, particularly in quantitative phase imaging, optical coherence tomography, flow cytometry, and imaging flow cytometry, which hampers their industrial and medical applications due to unreliable calibration and validation processes.

Innovation Solution

Development of spherical magnesium fluoride particles with diameters ranging from 5 µm to 15 µm, replicating the size and optical properties of somatic cells, which can be used as durable calibration and validation standards for marker-free imaging systems, enabling reliable system characterization and optimization under realistic conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional synthesis methods (precipitation, sol-gel, ammonia route) are used to produce magnesium fluoride particles, then particle formation is achieved, but particles larger than 2 μm cannot be produced with controlled size distribution

Engineering Contradiction:
Improveparticle size controlVSAvoidability to produce large monodisperse particles
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent changes the synthesis parameters by using a two-stage process: first forming nanoparticles via sol-gel method, then aggregating them into larger monodisperse particles through controlled ultrasonic treatment and pH adjustment. This parameter change enables production of particles larger than 2 μm with controlled size distribution, resolving the contradiction between particle size capability and manufacturing precision.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The synthesis process is segmented into distinct stages: (1) formation of primary nanoparticles through sol-gel, (2) aggregation of nanoparticles into larger particles, and (3) size selection through ultrasonic treatment. This segmentation allows independent optimization of each stage to achieve both large particle size and monodispersity, overcoming the limitations of conventional single-step methods.

Inventive Principle:
Principle #1Segmentation

2Manufacturing precision

If sol-gel synthesis using HF is used to produce magnesium fluoride particles, then uniform particles can be formed, but the process requires inert atmosphere, Schlenk apparatus, and produces corrosive HCl

Engineering Contradiction:
Improveparticle uniformityVSAvoidsynthesis process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent introduces an intermediary step using calcium fluoride as a temporary precursor that converts to magnesium fluoride through controlled reaction. This intermediary approach allows particle formation under simpler conditions without requiring inert atmospheres or specialized Schlenk apparatus, while maintaining particle uniformity. The intermediary compound facilitates the reaction and can be easily removed or converted.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent employs a disposable intermediate calcium fluoride compound that simplifies the synthesis process. Instead of using complex inert atmosphere techniques with HF, the method uses readily available calcium fluoride that reacts under normal conditions to form the desired magnesium fluoride particles, eliminating the need for expensive and complex equipment while maintaining product quality.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Ease of manufacture

If seawater synthesis is used to produce magnesium fluoride particles, then cost-effectiveness is improved, but environmental concerns and unknown chemical effects on particle size distribution arise

Engineering Contradiction:
Improvecost-effectivenessVSAvoidparticle size distribution control
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent applies local quality control by using purified water with controlled ionic composition rather than raw seawater. The water is treated to have specific local chemical properties (controlled ion concentration and composition) that promote uniform particle formation. This localized chemical environment ensures reliable particle size distribution while maintaining cost-effectiveness, avoiding the environmental and reliability issues of using raw seawater.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of these magnesium fluoride particles provides a reliable and durable solution for calibrating and validating marker-free imaging systems, enhancing measurement accuracy and opening new applications in clinical diagnostics and industrial uses.

Implementation Method 1

Mixing magnesium nitrate and sodium dihydrogen phosphate in water; adding an acid to dissolve the salt precipitated in step (i)

Methodology Applied
Scientific EffectPrecipitation: Precipitation

Implementation Method 2

heating the mixture to a maximum of 45°C; adding a fluoride source and mixing at a maximum of 45°C

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 3

heating the mixture in an autoclave at about 150°C to about 250°C to obtain the spherical material structure

Methodology Applied
Scientific EffectHydrothermal synthesis:

Data Source

PatentEP4498063A1Cell imitation and method for producing the same
Publication Date: 2025.01.29 WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
  • EP4498063A1 patent drawingFigure 1~2A
  • EP4498063A1 patent drawingFigure 2B~2C
  • EP4498063A1 patent drawingFigure 3~4

AI summary

In various embodiments, a cell imitation is provided, comprising a spherical material structure with a diameter of at least 3 µm, wherein the material comprises magnesium fluoride. Furthermore, an ensemble of cell imitations is provided, as well as their use for replicating the optical behavior of cells in an imaging technique. A method for producing a spherical material structure, preferably with a diameter of at least 3 µm, is also provided.